We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Brain Cancer

Expert Opinion / Cases · September 27, 2021

Managing Progressive Diffuse Midline Glioma H3 K27M-Mutant

Written by
L. Nicolas Gonzalez Castro MD, PhD

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Dorothy-Myra Sackey

    proceed on maintainance temozolomide for the mutation


  • Michela Pisani

    Cyberknife rt


  • Isacco Desideri

    Maintainance temozolomide plus focal irradation with any high precision radiotherapy technique


  • Oct 22, 2021

    Pending Moderator approval.
    Delete

Further Reading